CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-23 | Hull Hans Chief Business Officer | Grant or award | +40,150 | 251,708 | ||
| 2025-01-23 | Hull Hans Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +80,300 | 80,300 | ||
| 2025-01-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −15,936 | $11.20 | $179K | 211,558 |
| 2024-07-10 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,900 | $11.56 | $114K | 227,494 |
| 2024-07-09 | Hull Hans Chief Business Officer | Grant or award | +19,337 | 237,394 | ||
| 2024-01-23 | Hull Hans Chief Business Officer | Grant or award | +31,500 | 216,569 | ||
| 2024-01-23 | Hull Hans Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +63,000 | 63,000 | ||
| 2024-01-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,786 | $17.23 | $169K | 185,069 |
| 2023-08-04 | Hull Hans Chief Business Officer | Option exercise 10b5-1 | +8,791 | $2.08 | $18K | 214,905 |
| 2023-08-04 | Hull Hans Chief Business Officer | Sale 10b5-1 | −20,050 | $20.01 | $401K | 194,855 |
| 2023-08-04 | Hull Hans Chief Business Officer | Option exercise · Common Stock (Right to Buy) 10b5-1 | −8,791 | 31,367 | ||
| 2023-08-03 | Hull Hans Chief Business Officer | Sale 10b5-1 | −13,069 | $20.00 | $261K | 206,114 |
| 2023-08-03 | Hull Hans Chief Business Officer | Option exercise 10b5-1 | +1,800 | $2.08 | $4K | 207,914 |
| 2023-08-03 | Hull Hans Chief Business Officer | Sale 10b5-1 | +1,800 | $20.00 | $36K | 206,114 |
| 2023-08-03 | Hull Hans Chief Business Officer | Option exercise · Common Stock (Right to Buy) 10b5-1 | −1,800 | 40,158 | ||
| 2023-07-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −17,937 | $18.01 | $323K | 219,183 |
| 2023-07-14 | Hull Hans Chief Business Officer | Grant or award | +35,156 | 237,120 | ||
| 2023-03-30 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,036 | $26.52 | $240K | 201,964 |
| 2023-03-29 | Hull Hans Chief Business Officer | Grant or award | +17,578 | 211,000 | ||
| 2023-01-25 | Hull Hans Chief Business Officer | Grant or award | +54,000 | 192,191 |
Page 1 of 2 · 35 trades